EUVIMEDEUVIMED entdecken
Crossref

Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid

Wenwen Shangguan iD, Xiaowan Li, Yandan Wang, Zongqing Huang, Yuanzhen Dong, Meiqing Feng, Jun Feng

Bioconjugate Chemistry · 2024

DOI: 10.1021/acs.bioconjchem.4c00126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Wenwen Shangguan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, 201203 Shanghai, China. Hauptthemen laut MEDLINE: Fatty Acids, Ornithodoros, Complement C5. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disorder of complement response is a significant pathogenic factor causing some autoimmune and inflammation diseases. The Ornithodoros moubata Complement Inhibitor (OmCI), a small 17 kDa natural protein, was initially extracted from soft tick salivary glands. The protein was found binding to complement C5 specifically, inhibiting the activation of the complement pathway, which is a successful therapeutic basis of complement-mediated diseases. However, a short half-life due to rapid renal clearance is a common limitation of small proteins for clinical application. In this study, we extended the half-life of OmCI by modifying it with fatty acid, which was a method used to improve the pharmacokinetics of native peptides and proteins. Five OmCI mutants were initially designed, and single-site cysteine mutation was introduced to each of them. After purification, four OmCI mutants were obtained that showed similar in vitro biological activities. Three mutants of them were subsequently coupled with different fatty acids by nucleophilic substitution. In total, 15 modified derivatives were screened and tested for anticomplement activity in vitro. The results showed that coupling with fatty acid would not significantly affect their complement-inhibitory activity (CH50 and AH50). OmCIT90C-CM02 and OmCIT90C-CM05 were validated as the applicable OmCI bioconjugates for further pharmacokinetic assessments, and both showed improved plasma half-life in mice compared with unmodified OmCI (15.86, 17.96 vs 2.57 h). In summary, our data demonstrated that OmCI conjugated with fatty acid could be developed as the potential long-acting C5 complement inhibitor in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsOrnithodorosComplement C5AnimalsMiceDrug DesignHalf-LifeComplement Inactivator ProteinsComplement Inactivating AgentsHumans

Substanzen

Fatty AcidsComplement C5Complement Inactivator ProteinsComplement Inactivating Agents

Autor:innen und Institutionen

  • School of Pharmacy, Fudan University, 201203 Shanghai, China.
  • Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 201203 Shanghai, China.
  • Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, 310014 Hangzhou, China.
  • Shanghai Duomirui Biotechnology Co Ltd, 201203 Shanghai, China.

ORCID-Profile: Wenwen Shangguan

Zitieren

APA

Shangguan, W., Li, X., Wang, Y., Huang, Z., Dong, Y., Feng, M., & Feng, J. (2024). Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00126

Vancouver

Shangguan W, Li X, Wang Y, Huang Z, Dong Y, Feng M, et al. Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00126

BibTeX
@article{Shangguan2024,
  author = {Shangguan, Wenwen and Li, Xiaowan and Wang, Yandan and Huang, Zongqing and Dong, Yuanzhen and Feng, Meiqing and Feng, Jun},
  title = {Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid},
  journal = {Bioconjugate Chemistry},
  year = {2024},
  doi = {10.1021/acs.bioconjchem.4c00126}
}
Kostenlos starten →